Results 121 to 130 of about 39,155 (203)

The effects of salpingectomy on the serum level of anti-Müllerian hormone: A single-blind randomized controlled trial

, 2020
Objectives: Concerns exist over the effects of salpingectomy on ovarian function. This study aimed to assess the effects of salpingectomy on the serum level of anti-Müllerian hormone.
Sehat, M., Allamezadeh- Davani, S., Vahedpour, Z., Abedzadeh- Kalahroudi, M.   +3 more
core  

Paediatric reference intervals for plasma anti-Müllerian hormone:comparison of data from the Roche Elecsys assay and the Beckman Coulter Access assay using the same cohort of samples.

, 2019
BackgroundAutoanalyser methods for the measurement of anti-Müllerian hormone have been introduced into clinical laboratories but few reports of paediatric reference intervals using these new assays have been published.MethodsAfter prior evaluation of the
Burgoyne , N. J., Yates, Allen P., Hayden, Katharine, Tetlow, L, Chaloner, Christopher, Jopling, Helen; id_orcid   +5 more
core   +1 more source

The Role of Serum and Seminal Fluid Anti-Müllerian Hormone (AMH) in Differentiating Subtypes of Male Infertility.

مجلة كلية الطب
Background: Infertility is the inability to conceive after one year of unprotected intercourse, with male factors accounting for about 50% of cases. Anti-Müllerian hormone (AMH), a glycoprotein belonging to the Transforming growth factor beta family, is
Osama Ali Layih, Basil Oied Mohammed Saleh   +1 more
doaj   +1 more source

Predicting live birth following single euploid frozen‐embryo transfer via β‐hCG dynamics: iHOPE prognostic model with external validation

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 6, Page 824-835, June 2026.
ABSTRACT Objectives To determine the prognostic value of serum β‐human chorionic gonadotropin (β‐hCG) for predicting live birth following single euploid frozen‐embryo transfer (FET), and to develop and validate a prognostic model (iHOPE) for this purpose. Methods This retrospective cohort study used data from two large fertility practices.
E. Kalafat, B. Ata, R. Del Gallego, A. Freedman, L. R. Hoyos, I. Elkhatib, K. A. Miller, H. Fatemi, B. Lawrenz   +8 more
wiley   +1 more source

Persistent Müllerian duct syndrome due to anti-Müllerian hormone receptor 2 microdeletions: a diagnostic challenge

, 2020
The persistent Müllerian duct syndrome (PMDS) is defined by the persistence of Müllerian derivatives in an otherwise normally virilized 46,XY male. It is usually caused by mutations in either the anti-Müllerian hormone (AMH) or AMH receptor type 2 (AMHR2)
Picard, J Y, Tosca, L, Giltay, J C, Tachdjian, G, Bouvattier, C, Bouligand, J, Lambert, A S, Lecerf, L, Klijn, A J, Josso, N   +9 more
core  

Protein Tyrosine Phosphatase 1B‐Mediated Granulosa Cell Insulin Resistance Links Metabolic Stress to Aging‐Relevant Ovarian Dysfunction and Is Reversed by Gengnianchun

Aging Cell, Volume 25, Issue 6, June 2026.
Metabolic stress induces insulin resistance and upregulates PTP1B in granulosa cells, leading to aging‐relevant ovarian dysfunction. Gengnianchun (GNC) suppresses PTP1B, restores IRS1–AKT2–GLUT4 signaling, and preserves follicles, highlighting PTP1B as a therapeutic target for ovarian dysfunction in metabolically vulnerable states.
Yanqiu Rao, Ting Xu, Yan Ding, Jun Li, Lingyun Gao, Yun Wang, Wenjun Wang   +6 more
wiley   +1 more source

Fat reduction mediates the efficacy of intensive lifestyle interventions on fertility‐sparing treatment in overweight patients with endometrial cancer and intraepithelial neoplasia

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 1052-1063, June 2026.
Intensive lifestyle interventions‐based weight management targeting fat reduction may enhance fertility‐sparing treatment outcomes in overweight patients with endometrial cancer or its precursor. Our findings advocate the integration of body composition‐guided weight management into standardized protocols.
Sijia Liu, Li Li, Pengfei Wu, Lulu Wang, Qujia Gama, Manrong Wang, Jinyu Zhang, Liping Jin, Xuezhen Luo, Weiwei Shan, Bingyi Yang   +10 more
wiley   +1 more source

Anti Müllerian Hormone as a Predictor of Metabolic Syndrome in Polycystic Ovary Syndrome

, 2017
Objective: To evaluate whether Anti Müllerian Hormone (AMH) can be used as a predictor of metabolic syndrome in Polycystic Ovarian Syndrome (PCOS). Methods: This cross-sectional study was conducted in Yasmin Clinic, Dr.
Susanto, Cynthia A., Budi Wiweko, Cynthia A. Susanto, Wiweko, Budi   +3 more
core   +1 more source

Anti-Müllerian hormone: a critical factor for female fertility and reproductive health

, 2016
Anti-Müllerian hormone (AMH) is a glycoprotein produced by the granulosa cells of preantral and small antral follicles. AMH concentrations reflect ovarian physiology with high precision, thus serving as a more sensitive marker of the ovarian re­serve ...
Leszcz, Agnieszka, Tkaczuk-Włach, Joanna, Kotarski, Jan, Rzeszowska, Marzena; Ab ovo Sp. z o.o., Family Health Center, Lublin, Poland, Putowski, Lechosław, Hałabiś, Magdalena, Polak, Grzegorz   +6 more
core   +1 more source

Comparison of two different anti-mullerian hormone measurement methods and evaluation of anti-mullerian hormone in polycystic ovary syndrome

Türk Biyokimya Dergisi
Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine condition that influences 15–20 % of women at their fertile age. In this academic work, we aimed to research serum anti-mullerian hormone (AMH) levels using the Vidas® and Atellica® methods ...
Gök Gamze, Bal Ceylan, Seçen Elçin İşlek, Desdicioğlu Raziye, Akbıyık Filiz, Yılmaz Gülsen   +5 more
doaj   +1 more source